(HealthDay)—For healthy adults from Sierra Leon, the recombinant type-5 vector-based Ebola vaccine is safe and immunogenic, according to a study published online Dec. 21 in The Lancet.
Dec 27, 2016
0
0
Scientists potentially have found a way to disrupt Zika and similar viruses from spreading in the body.
Jun 17, 2016
0
512
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit ...
Jun 9, 2016
0
10
Foodborne illness outbreaks do more than make us sick. Not only can the U.S. economy suffer as a result of reduced worker productivity, particular sectors of the farming industry can experience negative consumer perception, ...
Mar 23, 2016
0
3
For years, researchers have noted a tantalizing link between some neurologic conditions and certain species of the herpes virus. In patients with Alzheimer's disease, multiple sclerosis, and cerebellar ataxia, among other ...
Dec 4, 2015
1
801
Viral replication and spread throughout a host organism employs many proteins, but the process is not very well understood. Scientists at A*STAR have led a collaborative study to learn which host factors play a key role in ...
Nov 18, 2015
0
8
How retroviruses like HIV spread in their hosts had been unknown—until a Yale team devised a way to watch it actually happen in a living organism. The elaborate and sometimes surprising steps the virus takes to reach and ...
Oct 2, 2015
3
147
Virologists at Emory University School of Medicine, Yerkes National Primate Research Center, and Children's Healthcare of Atlanta have uncovered a critical detail explaining how HIV assembles its infectious yet stealthy clothing.
Jun 2, 2015
0
51
A team of biologists from San Diego State University has developed a platform for identifying drugs that could prove to be effective against a variety of viral diseases. In a pair of recent articles in the Journal of Biomolecular ...
Apr 14, 2015
0
69
(HealthDay)—Rapivab (peramivir) has been approved by the U.S. Food and Drug Administration to treat influenza.
Dec 22, 2014
0
0
